L. Báez

发表

A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999

P. D. de Alarcon, M. Metzger, M. Bonilla, 2014, Pediatric blood & cancer.

Protocol‐based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—Part II

C. Rodríguez-Galindo, G. Masera, R. Barr, 2007, Pediatric blood & cancer.

Pain and Treatment of Pain in Minority Patients with Cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study

C. Cleeland, K. Pandya, P. Loehrer, 1997, Annals of Internal Medicine.

Randomized trial of 3-hour versus 24-hour infusion of high-dose paclitaxel in patients with metastatic or locally advanced breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26.

E. Mamounas, A. Brown, S. Anderson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma.

J. Ajani, R. Winn, T. Pollock, 1994, Cancer investigation.

The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40.

G. Tang, J. Costantino, C. Geyer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of malnutrition on treatment‐related morbidity and survival of children with cancer in Nicaragua

S. Luna-Fineman, Allison Pribnow, L. Báez, 2017, Pediatric blood & cancer.

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.

S. Lippman, W. Hong, R. Winn, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer

J. Ajani, C. Takimoto, C. Becerra, 2005, Investigational New Drugs.

Signal Transduction Proteins in Tumors From Puerto Rican and Caucasian Gastric Adenocarcinoma Patients: Expression Differences With Potential for Specific Targeted Therapies

R. Jove, D. Sullivan, C. Muro-Cacho, 2008, Digestive Diseases and Sciences.

Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy

R. DeJager, Shreyaskumar R Patel, D. Rushing, 2006, Cancer.

Toxic epidermal necrolysis, an unusual adverse effect of Capecitabine

L. Báez, L. Baez, Yelitza Ruiz, 2008 .

Molecular characterization and prospective evaluation of pathological response and outcomes with neoadjuvant therapy in metaplastic triple-negative breast cancer.

Jeffrey T. Chang, Jason B. White, G. Hortobagyi, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer.

R. Millikan, R. Winn, C. Logothetis, 2001, Urologic oncology.

Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293).

S. Lipsitz, A. Benson, C. Falkson, 2000, American journal of clinical oncology.

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

M. Metzger, S. Luna-Fineman, E. Castellanos, 2009 .